Bldg. 560, wing 2, floor 1 refurbishment
Ended Awarded Last action
- Contract number
- HHSN26100047
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,735,356
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $6,735,356.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,106 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $118,779 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $6,624,683 |
About this award
Leidos Biomedical Research Inc. was awarded a $6,735,356.03 cost-plus-fixed-fee delivery order contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract has no set-aside designation. It is for the refurbishment of Building 560, Wing 2, Floor 1 at Fort Detrick, Maryland, with work to be completed by July 31, 2020. Leidos Biomedical Research is a subsidiary of Leidos Holdings, Inc. and will serve as the prime contractor, drawing on its experience providing facilities operations and maintenance in support of biomedical research programs. The National Cancer Institute aims to advance cancer research through its research centers and grantee institutions.
Quick answers
Who was awarded contract HHSN26100047?
HHSN26100047 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2017.
How much is contract HHSN26100047 worth?
The government has obligated $6,735,356 on HHSN26100047.
Is contract HHSN26100047 an order under another contract?
Yes. HHSN26100047 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100047 competed?
The extent of competition for HHSN26100047 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award